Free tool
FAERS Monitor: Drizalma Sprinkle
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 212516 or its brand name (Drizalma Sprinkle, Duloxetine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
52,942
Serious
38,285
72% of reports
Hospitalization
17,428
Death reported
5,746
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective4,198
- fatigue3,892
- nausea3,793
- off label use3,210
- pain2,934
- headache2,804
- diarrhoea2,737
- dizziness2,319
- fall2,246
- vomiting2,032
- toxicity to various agents1,892
- arthralgia1,876
- completed suicide1,814
- dyspnoea1,759
- drug interaction1,752
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 23 |
| 2006 | 42 |
| 2007 | 72 |
| 2008 | 145 |
| 2009 | 92 |
| 2010 | 129 |
| 2011 | 149 |
| 2012 | 124 |
| 2013 | 382 |
| 2014 | 1,019 |
| 2015 | 1,785 |
| 2016 | 2,557 |
| 2017 | 3,266 |
| 2018 | 4,324 |
| 2019 | 5,068 |
| 2020 | 5,408 |
| 2021 | 4,825 |
| 2022 | 4,822 |
| 2023 | 4,722 |
| 2024 | 4,707 |
| 2025 | 5,172 |
| 2026 | 4,109 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,001,217 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| completed suicideSignal | 1,814 | 8.8 | 8.4 | 12,342 |
| toxicity to various agentsSignal | 1,892 | 4.5 | 4.3 | 5,124 |
| drug interactionSignal | 1,752 | 4.4 | 4.2 | 4,625 |
| fallSignal | 2,246 | 2.7 | 2.6 | 2,410 |
| fatigue | 3,892 | 2.0 | 1.9 | 1,982 |
| nausea | 3,793 | 1.9 | 1.9 | 1,695 |
| pain | 2,934 | 1.9 | 1.8 | 1,285 |
| dizziness | 2,319 | 1.9 | 1.8 | 924 |
| arthralgia | 1,876 | 1.8 | 1.7 | 671 |
| headache | 2,804 | 1.8 | 1.7 | 983 |
| vomiting | 2,032 | 1.7 | 1.6 | 623 |
| diarrhoea | 2,737 | 1.7 | 1.6 | 787 |
| off label use | 3,210 | 1.5 | 1.4 | 480 |
| drug ineffective | 4,198 | 1.3 | 1.2 | 250 |
| dyspnoea | 1,759 | 1.2 | 1.2 | 80 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.